Investigating the feasibility of introducing personalised exercise prescription from point-of-diagnosis in individuals receiving treatment for early-stage breast or colon cancer in Christchurch, New Zealand.
Not Applicable
Recruiting
- Conditions
- Breast cancerColon cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Breast
- Registration Number
- ACTRN12621001352897
- Lead Sponsor
- niversity of Canterbury
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Men and women able to give informed written consent.
18 years or older with adequate hematologic, renal and liver function.
Treatment for primary cancer; chemotherapy treatment, radiation therapy, or surgery commenced within the last twelve months
Good performance status (i.e. Eastern Cooperative Oncology Group (EGOC) performance status of 0–1).
Early stage breast or colon cancer (stage I-III, no distant metastasis).
Exclusion Criteria
Acute infectious diseases.
Severe cardiovascular (e.g. unstable ischemic heart disease, uncontrolled arrhythmia) or respiratory (e.g. shortness of breath at rest) disease.
Severe anaemia (Hb<100).
Unable to read and speak English
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine feasibility of introducing a supervised, personalised exercise programme from point of diagnosis through surgery and chemotherapy in individuals with early-stage breast or colon cancer in the New Zealand clinical setting. This will be evaluated by the composite primary endpoint of participant attendance (ratio of total attended to planned treatments >70%) and loss to follow-up (non-completion of exercise intervention assessments (< 20% LTF). Attendance checklists will be used to monitor attendance and any lost to follow up participants.[On completion of the exercise programme. ]
- Secondary Outcome Measures
Name Time Method